Stock Overview
Ionis Pharmaceuticals Inc (IONS)
NASDAQ · Healthcare · Biotechnology
Ionis Pharmaceuticals Inc is a Healthcare company with a market capitalization of $13.42B.
Market Cap
$13.42B
Forward P/E
90.9
Price/Sales
12.7
Price/Book
27.3
EV/EBITDA
135.8
Beta
0.37
EPS (TTM)
$-2.01
Profit Margin
-30.9%
ROE
-67.6%
52W High
$86.74
52W Low
$39.37
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Revenue
$944.00M
Gross Profit
$928.00M
Operating Income
-$382.00M
Net Income
-$381.00M
Free Cash Flow
-$320.03M
Total Debt
$1.80B
Cash & Equivalents
$372.26M
Shareholder Equity
$489.09M
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 29, 2026 | $-0.30 | $-0.77 | +61.0% |
| Q4 2025 | February 25, 2026 | $-1.15 | $-1.33 | +13.7% |
| Q3 2025 | October 29, 2025 | $-0.61 | $-1.05 | +41.9% |
| Q2 2025 | July 30, 2025 | $0.85 | $0.16 | +431.3% |
| Q1 2025 | April 30, 2025 | $-0.93 | $-1.13 | +17.7% |
| Q4 2024 | February 19, 2025 | $-0.43 | $-0.84 | +49.0% |
Other Biotechnology Stocks
Frequently Asked Questions
What is Ionis Pharmaceuticals Inc's market cap?
As of June 29, 2026, Ionis Pharmaceuticals Inc (IONS) has a market capitalization of $13.42B.
Does Ionis Pharmaceuticals Inc pay a dividend?
Ionis Pharmaceuticals Inc does not currently pay a dividend.
What sector is IONS in?
Ionis Pharmaceuticals Inc is in the Healthcare sector, specifically the Biotechnology industry.
What was Ionis Pharmaceuticals Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Ionis Pharmaceuticals Inc reported revenue of $944.00M and net income of -$381.00M.
Ask your own questions about IONS
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.